… of transthyretin cardiac amyloidosis. ACE-I, angiotensin-converting enzyme inhibitor; ARB,
angiotensin II receptor blocker; CCB, calcium-channel blocker; CMR, cardiac magnetic …

… Diagnostic techniques in transthyretin cardiac amyloidosis (ATTR). A: electrocardiogram of
a patient with wild-type transthyretin amyloidosis (… with mutant transthyretin amyloidosis with …

… light chain amyloidosis (AL) caused by monoclonal immunoglobulin light chains and
transthyretin amyloidosis (ATTR) caused by either mutated or wild-type transthyretin aggregates. …

… asymptomatic transthyretin amyloidosis gene mutation carriers for cardiac involvement, …
treatment. We will additionally focus on recent advances in treatment for transthyretin amyloidosis…

… international protocols and guidelines for diagnosis of transthyretin amyloid cardiomyopathy
(ATTR-CM). The invasive and non-invasive diagnosis techniques and their combinations …

… findings in heart failure populations. This article will review ATTR cardiac amyloidosis to …
a definitive diagnosis when there is a clinical suspicion of amyloidosis and provide the most …

… Nuclear imaging has a role in the diagnosis of transthyretin amyloid cardiomyopathy. …
specific to cardiac amyloidosis and any severe cardiomyopathy with severe myocardial injury may …

… amyloid production, cardiac amyloidosis is a myocardial disease characterized by extracellular
amyloid infiltration throughout the heart… transthyretin-associated cardiac amyloidosis, and …

… Advances in the diagnosis of amyloid cardiomyopathy … noninvasive diagnosis of transthyretin
cardiac amyloidosis (ATTR… accurate first diagnostic step for light chain cardiac amyloidosis (…

… Given that the prevalence of cardiac amyloidosis is … delayed diagnosis results in worse
outcomes. However, much is not known: the natural history of subclinical TTR cardiac amyloidosis…